 Vitaly Kheyfets
Concepts (192)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Artery | 19 | 2024 | 1097 | 2.580 |
Why?
| | Hypertension, Pulmonary | 15 | 2024 | 1894 | 2.310 |
Why?
| | Ventricular Dysfunction, Right | 8 | 2024 | 231 | 1.880 |
Why?
| | Ventricular Function, Right | 13 | 2024 | 276 | 1.480 |
Why?
| | Computer Simulation | 10 | 2024 | 939 | 1.460 |
Why?
| | Vascular Resistance | 5 | 2024 | 371 | 1.370 |
Why?
| | Pulmonary Circulation | 7 | 2024 | 431 | 1.300 |
Why?
| | Magnetic Resonance Imaging, Cine | 9 | 2021 | 185 | 1.280 |
Why?
| | Heart Ventricles | 11 | 2024 | 781 | 1.250 |
Why?
| | Models, Cardiovascular | 6 | 2024 | 191 | 0.880 |
Why?
| | Regional Blood Flow | 5 | 2021 | 463 | 0.750 |
Why?
| | Hemodynamics | 7 | 2024 | 1090 | 0.710 |
Why?
| | Pulmonary Embolism | 1 | 2023 | 212 | 0.700 |
Why?
| | Ventilators, Mechanical | 1 | 2020 | 56 | 0.670 |
Why?
| | Positive-Pressure Respiration | 1 | 2020 | 76 | 0.660 |
Why?
| | Fibrosis | 3 | 2021 | 526 | 0.630 |
Why?
| | Magnetic Resonance Angiography | 3 | 2017 | 234 | 0.600 |
Why?
| | Patient-Specific Modeling | 2 | 2017 | 39 | 0.560 |
Why?
| | Hydrodynamics | 3 | 2018 | 40 | 0.550 |
Why?
| | Algorithms | 5 | 2020 | 1616 | 0.540 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 340 | 0.490 |
Why?
| | Coronavirus Infections | 1 | 2020 | 334 | 0.480 |
Why?
| | Stress, Mechanical | 4 | 2019 | 467 | 0.480 |
Why?
| | Bandages | 1 | 2014 | 32 | 0.450 |
Why?
| | Arterial Pressure | 4 | 2020 | 118 | 0.430 |
Why?
| | Patients | 1 | 2015 | 169 | 0.420 |
Why?
| | Blood Flow Velocity | 5 | 2019 | 406 | 0.420 |
Why?
| | Gravitation | 1 | 2013 | 15 | 0.420 |
Why?
| | Ventricular Remodeling | 4 | 2024 | 255 | 0.410 |
Why?
| | Cellulose | 1 | 2013 | 61 | 0.410 |
Why?
| | Materials Testing | 1 | 2014 | 342 | 0.400 |
Why?
| | Ventricular Pressure | 2 | 2024 | 45 | 0.390 |
Why?
| | Drug Carriers | 1 | 2013 | 119 | 0.390 |
Why?
| | Stroke Volume | 7 | 2022 | 592 | 0.380 |
Why?
| | Wound Healing | 1 | 2014 | 307 | 0.370 |
Why?
| | Hypertension | 1 | 2020 | 1243 | 0.360 |
Why?
| | Gene Expression Regulation | 1 | 2020 | 2542 | 0.350 |
Why?
| | MicroRNAs | 1 | 2017 | 679 | 0.350 |
Why?
| | Cardiac Catheterization | 6 | 2021 | 520 | 0.350 |
Why?
| | Anti-Infective Agents | 1 | 2013 | 247 | 0.340 |
Why?
| | Polymers | 1 | 2014 | 477 | 0.340 |
Why?
| | Biomarkers | 2 | 2023 | 3968 | 0.280 |
Why?
| | Image Interpretation, Computer-Assisted | 3 | 2018 | 252 | 0.270 |
Why?
| | Disease Models, Animal | 5 | 2024 | 4078 | 0.260 |
Why?
| | Humans | 36 | 2024 | 129625 | 0.250 |
Why?
| | Vascular Stiffness | 4 | 2017 | 467 | 0.240 |
Why?
| | Hypertrophy, Right Ventricular | 2 | 2023 | 145 | 0.210 |
Why?
| | Forecasting | 2 | 2024 | 361 | 0.210 |
Why?
| | Animals | 10 | 2024 | 35391 | 0.210 |
Why?
| | Mice, Inbred C57BL | 3 | 2024 | 5455 | 0.210 |
Why?
| | Child | 12 | 2024 | 20884 | 0.200 |
Why?
| | Fontan Procedure | 1 | 2024 | 174 | 0.190 |
Why?
| | Blood Pressure | 2 | 2021 | 1736 | 0.190 |
Why?
| | Male | 20 | 2024 | 63670 | 0.190 |
Why?
| | Lung | 2 | 2022 | 3938 | 0.190 |
Why?
| | Perfusion Imaging | 2 | 2019 | 56 | 0.190 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2021 | 51 | 0.180 |
Why?
| | Hypoxia | 3 | 2023 | 1084 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2021 | 129 | 0.180 |
Why?
| | Transcriptome | 2 | 2024 | 876 | 0.170 |
Why?
| | Predictive Value of Tests | 3 | 2021 | 1947 | 0.170 |
Why?
| | Imaging, Three-Dimensional | 1 | 2024 | 528 | 0.170 |
Why?
| | Proof of Concept Study | 1 | 2020 | 69 | 0.170 |
Why?
| | Tacrolimus | 1 | 2021 | 193 | 0.170 |
Why?
| | Respiratory Mechanics | 1 | 2020 | 64 | 0.170 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2018 | 984 | 0.160 |
Why?
| | Cardiac Output | 2 | 2017 | 156 | 0.160 |
Why?
| | Gene Expression Profiling | 2 | 2024 | 1687 | 0.160 |
Why?
| | Ventricular Function, Left | 2 | 2020 | 528 | 0.160 |
Why?
| | Image Processing, Computer-Assisted | 2 | 2021 | 740 | 0.160 |
Why?
| | Mice | 5 | 2024 | 16961 | 0.150 |
Why?
| | Female | 17 | 2024 | 68734 | 0.150 |
Why?
| | Sensitivity and Specificity | 3 | 2022 | 1843 | 0.150 |
Why?
| | Cognitive Dysfunction | 1 | 2023 | 346 | 0.150 |
Why?
| | Thermodilution | 1 | 2017 | 13 | 0.140 |
Why?
| | Pulmonary Wedge Pressure | 1 | 2017 | 66 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2023 | 514 | 0.140 |
Why?
| | Betacoronavirus | 1 | 2020 | 250 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 3 | 2024 | 3394 | 0.140 |
Why?
| | Echocardiography, Doppler | 1 | 2018 | 108 | 0.140 |
Why?
| | Lung Diseases | 1 | 2023 | 741 | 0.130 |
Why?
| | Aortic Diseases | 1 | 2017 | 113 | 0.130 |
Why?
| | Prospective Studies | 5 | 2021 | 7135 | 0.130 |
Why?
| | Echinococcosis, Pulmonary | 1 | 2015 | 7 | 0.120 |
Why?
| | Nitric Oxide | 1 | 2021 | 895 | 0.120 |
Why?
| | Aorta, Thoracic | 1 | 2017 | 263 | 0.120 |
Why?
| | Ventricular Dysfunction, Left | 1 | 2018 | 385 | 0.110 |
Why?
| | Adhesiveness | 1 | 2014 | 19 | 0.110 |
Why?
| | Rats | 1 | 2023 | 5483 | 0.110 |
Why?
| | Oxygen Consumption | 1 | 2017 | 672 | 0.110 |
Why?
| | Contrast Media | 1 | 2017 | 393 | 0.110 |
Why?
| | Aorta | 1 | 2017 | 408 | 0.110 |
Why?
| | Reproducibility of Results | 3 | 2017 | 3080 | 0.110 |
Why?
| | Administration, Intravaginal | 1 | 2013 | 16 | 0.110 |
Why?
| | Compliance | 1 | 2013 | 44 | 0.100 |
Why?
| | Blood Circulation | 1 | 2013 | 41 | 0.100 |
Why?
| | Child, Preschool | 5 | 2021 | 10490 | 0.100 |
Why?
| | Bioengineering | 1 | 2013 | 19 | 0.100 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2739 | 0.100 |
Why?
| | Aneurysm, Ruptured | 1 | 2013 | 34 | 0.100 |
Why?
| | Solutions | 1 | 2013 | 150 | 0.100 |
Why?
| | Aneurysm | 1 | 2013 | 31 | 0.100 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 199 | 0.100 |
Why?
| | Fibroblasts | 3 | 2023 | 953 | 0.100 |
Why?
| | Vascular Remodeling | 2 | 2024 | 192 | 0.100 |
Why?
| | Adolescent | 7 | 2021 | 20412 | 0.100 |
Why?
| | Retrospective Studies | 5 | 2021 | 14522 | 0.100 |
Why?
| | Epithelium | 1 | 2013 | 314 | 0.100 |
Why?
| | Surface Properties | 1 | 2013 | 397 | 0.100 |
Why?
| | Pandemics | 1 | 2020 | 1491 | 0.090 |
Why?
| | Aortic Aneurysm, Abdominal | 1 | 2013 | 132 | 0.090 |
Why?
| | Pressure | 1 | 2013 | 237 | 0.090 |
Why?
| | Swine | 1 | 2014 | 764 | 0.090 |
Why?
| | Vagina | 1 | 2013 | 174 | 0.090 |
Why?
| | Time Factors | 5 | 2021 | 6555 | 0.090 |
Why?
| | Middle Aged | 7 | 2024 | 31136 | 0.090 |
Why?
| | Case-Control Studies | 4 | 2019 | 3378 | 0.080 |
Why?
| | Heart Failure | 1 | 2023 | 2133 | 0.080 |
Why?
| | Skin | 1 | 2014 | 727 | 0.080 |
Why?
| | Precision Medicine | 1 | 2013 | 387 | 0.080 |
Why?
| | Signal Transduction | 1 | 2021 | 4931 | 0.070 |
Why?
| | Endothelial Cells | 2 | 2023 | 749 | 0.070 |
Why?
| | Disease Progression | 1 | 2015 | 2627 | 0.070 |
Why?
| | Follow-Up Studies | 3 | 2021 | 4894 | 0.070 |
Why?
| | Elasticity | 2 | 2019 | 195 | 0.070 |
Why?
| | Proteomics | 2 | 2023 | 1055 | 0.060 |
Why?
| | Myocardium | 2 | 2021 | 980 | 0.060 |
Why?
| | Age Factors | 3 | 2019 | 3152 | 0.060 |
Why?
| | Infant | 4 | 2021 | 8995 | 0.060 |
Why?
| | Cohort Studies | 1 | 2015 | 5426 | 0.060 |
Why?
| | Vena Cava, Inferior | 1 | 2024 | 68 | 0.050 |
Why?
| | Amyloidogenic Proteins | 1 | 2023 | 16 | 0.050 |
Why?
| | Microvessels | 1 | 2024 | 82 | 0.050 |
Why?
| | tau Proteins | 1 | 2023 | 76 | 0.050 |
Why?
| | Mechanotransduction, Cellular | 1 | 2023 | 111 | 0.050 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2023 | 374 | 0.050 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2023 | 274 | 0.050 |
Why?
| | Endothelium-Dependent Relaxing Factors | 1 | 2021 | 16 | 0.050 |
Why?
| | Mice, Mutant Strains | 1 | 2021 | 298 | 0.040 |
Why?
| | Young Adult | 4 | 2019 | 12455 | 0.040 |
Why?
| | Amyloid beta-Peptides | 1 | 2023 | 211 | 0.040 |
Why?
| | Cluster Analysis | 1 | 2022 | 482 | 0.040 |
Why?
| | Cattle | 1 | 2023 | 977 | 0.040 |
Why?
| | Aged | 4 | 2022 | 22061 | 0.040 |
Why?
| | Myocytes, Cardiac | 1 | 2024 | 499 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2022 | 427 | 0.040 |
Why?
| | Suture Techniques | 1 | 2020 | 118 | 0.040 |
Why?
| | Dimensional Measurement Accuracy | 1 | 2019 | 13 | 0.040 |
Why?
| | Peptide Fragments | 1 | 2023 | 693 | 0.040 |
Why?
| | Administration, Inhalation | 1 | 2021 | 667 | 0.040 |
Why?
| | Exercise Tolerance | 1 | 2020 | 273 | 0.040 |
Why?
| | Numerical Analysis, Computer-Assisted | 1 | 2018 | 19 | 0.040 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.040 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 150 | 0.040 |
Why?
| | Prognosis | 2 | 2017 | 3774 | 0.040 |
Why?
| | Finite Element Analysis | 1 | 2018 | 72 | 0.040 |
Why?
| | Rheology | 1 | 2018 | 90 | 0.040 |
Why?
| | Genomics | 1 | 2023 | 718 | 0.040 |
Why?
| | Viscosity | 1 | 2018 | 90 | 0.040 |
Why?
| | Phantoms, Imaging | 1 | 2018 | 137 | 0.030 |
Why?
| | Printing, Three-Dimensional | 1 | 2018 | 88 | 0.030 |
Why?
| | Aftercare | 1 | 2019 | 203 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 419 | 0.030 |
Why?
| | Dilatation, Pathologic | 1 | 2017 | 60 | 0.030 |
Why?
| | Shear Strength | 1 | 2017 | 67 | 0.030 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 792 | 0.030 |
Why?
| | Adult | 3 | 2024 | 35599 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2019 | 301 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 642 | 0.030 |
Why?
| | Pulse Wave Analysis | 1 | 2017 | 248 | 0.030 |
Why?
| | Cognition | 1 | 2023 | 1129 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2023 | 4084 | 0.030 |
Why?
| | Linear Models | 1 | 2018 | 819 | 0.030 |
Why?
| | Reference Values | 1 | 2017 | 794 | 0.030 |
Why?
| | Cytokines | 1 | 2023 | 2021 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1293 | 0.030 |
Why?
| | Area Under Curve | 1 | 2015 | 304 | 0.030 |
Why?
| | Phenotype | 1 | 2023 | 3075 | 0.030 |
Why?
| | Macrophages | 1 | 2022 | 1488 | 0.030 |
Why?
| | Myocardial Contraction | 1 | 2015 | 335 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 503 | 0.030 |
Why?
| | Biomechanical Phenomena | 1 | 2017 | 764 | 0.030 |
Why?
| | Societies, Scientific | 1 | 2013 | 45 | 0.030 |
Why?
| | Risk Factors | 2 | 2017 | 9786 | 0.020 |
Why?
| | Survival Rate | 1 | 2017 | 1872 | 0.020 |
Why?
| | Angiography | 1 | 2013 | 196 | 0.020 |
Why?
| | Feasibility Studies | 1 | 2015 | 869 | 0.020 |
Why?
| | Congresses as Topic | 1 | 2013 | 216 | 0.020 |
Why?
| | Inflammation | 1 | 2022 | 2750 | 0.020 |
Why?
| | Tomography, X-Ray Computed | 1 | 2019 | 2512 | 0.020 |
Why?
| | Kinetics | 1 | 2013 | 1645 | 0.020 |
Why?
| | Risk Assessment | 1 | 2013 | 3262 | 0.010 |
Why?
|
|
Kheyfets's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|